Hey Jane

High-Level Overview

Hey Jane is a New York-based telehealth company founded in 2019 (with operations launching in 2021) that provides virtual medication abortion services, delivering FDA-approved abortion pills directly to patients' homes in 23 U.S. states where legal.[3][5] It serves over 100,000 patients seeking discreet, affordable reproductive care, offering consultations within one day, sliding-scale pricing as low as $0 with insurance, and additional services like birth control, emergency contraception, and infection treatments.[3][5][7] The company solves access barriers amid clinic closures and restrictions post-Roe v. Wade by enabling telemedicine without in-person visits, at less than half the average in-clinic cost, while ensuring HIPAA-compliant, evidence-based care supported by an in-house clinical team.[1][3][4][6]

Hey Jane has demonstrated strong growth, raising nearly $10 million in venture capital by early 2023 and expanding from abortion pills to holistic reproductive health, with high patient satisfaction (4.94★ average rating).[2][3] Its model emphasizes privacy, speed, and support, including 24/7 nursing lines and partnerships with abortion funds.[5]

Origin Story

Hey Jane was co-founded in 2019 by Kaitlin (Kiki) Freedman, who serves as CEO, and Gaby Izarra, both with prior experience at Silicon Valley firms like Uber, Webflow, and Autodesk.[1][4] The idea emerged amid growing U.S. abortion restrictions and clinic closures, launching fully in January 2021 as one of the first legal telemedicine providers for medication abortion.[3][5] Early traction accelerated post-Roe v. Wade in 2022, serving nearly 10,000 patients initially and scaling to over 20,000 by January 2023, while raising $3.6 million (later nearly $10 million) in funding.[1][2]

Pivotal moments include rapid expansion to 23 states, independent certifications from the National Abortion Federation and LegitScript, and research validating its safety and effectiveness.[3][5][6] By 2025, it had reached 100,000+ patients and begun supporting studies on telehealth abortion and Medicaid access.[3]

Core Differentiators

• Tech-Enabled, Asynchronous Care Model: Patients get clinical consultations in one day via app or web, with discreet mail delivery, real-time chat support, and 24/7 nursing—addressing both physical and emotional needs in a way unmatched by traditional clinics.[3][5][6]
• Affordability and Accessibility: Sliding-scale pricing ($0 with insurance), payment installments, abortion fund partnerships, and service in 23 states at half the in-clinic cost, without requiring visits.[3][4][5]
• Privacy and Compliance Focus: HIPAA-aligned operations, discreet packaging, and post-2022 removal of most third-party trackers (retaining only fraud-prevention tools like Stripe); certified by major verifiers.[1][3][5]
• Evidence-Based Safety and Expansion: Backed by internal data and research showing high effectiveness; expanded beyond abortion to birth control, emergency contraception, and potential maternal mental health.[2][6][7]
• Female-Founded Leadership: Led by Freedman and a team including Chief Medical Officer Dr. Amy Potter, emphasizing judgment-free, patient-centered care.[3][4][5]

Role in the Broader Tech Landscape

Hey Jane rides the telemedicine boom in reproductive health, accelerated by Roe v. Wade's 2022 overturn, which spiked demand for mail-order abortion amid state bans and clinic strains.[1][2][6] Its timing leverages FDA allowances for telehealth abortion, positioning it as a leader in virtual clinics—scaling access where 1 in 5 U.S. women face barriers.[3][6]

Market forces like insurance integration (e.g., Collective Health partnerships), rising stigma around in-person care, and tech adoption favor its growth, influencing the ecosystem by funding research, normalizing async telehealth, and pressuring legacy providers to digitize.[3][5][6][7] As a female-founded startup in healthcare tech, it exemplifies how VC-backed platforms expand equitable care in a fragmented $50B+ U.S. reproductive health market.[2][4]

Quick Take & Future Outlook

Hey Jane is poised for further expansion into stigmatized areas like maternal mental health and more sexual health services, building on 100,000+ patients and research partnerships.[2][3] Trends like AI-driven triage, broader insurance adoption, and federal telehealth policy shifts will amplify its scale, potentially doubling reach amid ongoing restrictions. Its influence may evolve from niche abortion provider to comprehensive virtual reproductive health leader, reshaping access through tech—echoing its origins as a post-Roe lifeline now trusted by thousands.[3][5][6]